TotalMarketCap

Zhengye Biotechnology

ZYBTNasdaq ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$66.822 M

$1.41 +2.92%

Close of 6 Nov 2026

As of 6 Nov 2026, Zhengye Biotechnology (ZYBT) has a market capitalization of $66.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$16.6M

#3024 by revenue

Earnings

-$9.98M

Loss-making

Shares outstanding

47,391,376

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #308Rani TherapeuticsRANI$71.7M
  2. #309Acrivon TherapeuticsACRV$67.3M
  3. #310Zhengye BiotechnologyZYBT$66.8M
  4. #311Coya TherapeuticsCOYA$66.4M
  5. #312LifevantageLFVN$66.0M

What if Zhengye Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$595,823.04

Per share 422,570× higher

Bitcoin $1.53T

$32,238.95

Per share 22,865× higher

Apple $5.02T

$105,837.46

Per share 75,062× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Zhengye Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.